Recombinant vesicular stomatitis virus vaccine (TFF Pharmaceuticals/USAMRIID)

N/A

Report date: 2025/05/30 14:54:07

Base Information

Drug NameRecombinant vesicular stomatitis virus vaccine (TFF Pharmaceuticals/USAMRIID)
Drug Alias NameViral haemorrhagic fevers vaccineInhaled vesicular stomatitis virus vaccineFilovirus vaccine
ClassificationVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEncephalomyelitis, Venezuelan Equine
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTff Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTff Pharmaceuticals IncUS Army Medical Research Institute of Infectious Diseases
Active IndicationsN/A
Inactive IndicationsEncephalomyelitis, Venezuelan Equine

Other Information

ATC CodeN/A
Related LinksN/A